CD274 and neoplasm: Our results revealed that B1451 is capable of reversing immune evasion, inhibiting tumor metastasis, improving the tumor microenvironment, and exhibiting synergistic anti-tumor effects through simultaneous targeting of PD-L1 and αvβ3.